Peeling Back The Layers: Exploring NovoCure Through Analyst Insights
Peeling Back The Layers: Exploring NovoCure Through Analyst Insights
揭开层面：通过分析师见解探索NovoCure
5 analysts have shared their evaluations of NovoCure (NASDAQ:NVCR) during the recent three months, expressing a mix of bullish and bearish perspectives.
最近三个月来，有5位分析师分享了他们对NovoCure（纳斯达克股票代码：NVCR）的评估，他们表达了看涨和看跌的观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $20.0, a high estimate of $24.00, and a low estimate of $15.00. This upward trend is apparent, with the current average reflecting a 11.11% increase from the previous average price target of $18.00.
分析师评估的12个月目标股价揭示了进一步的见解，平均目标价为20.0美元，最高估计为24.00美元，低估值为15.00美元。这种上升趋势显而易见，当前的平均价格较之前的平均目标价18.00美元上涨了11.11％。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细明细
An in-depth analysis...
对分析师...
登录免费看全文
登录/注册